Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of the effect of atorvastatin and rosuvastatin on reducing LDL
IRCT20151020024625N22Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin and rosuvastatin in dyslipidemia (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoint: LDL reduction. Started Oct 2024; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on IRCT20151020024625N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151020024625N22.